OPKO Health Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Public

  • Employees
  • 3,930

Employees

  • Stock Symbol
  • OPK

Stock Symbol

  • Investments
  • 44

  • Share Price
  • $1.61
  • (As of Wednesday Closing)

OPKO Health General Information

Description

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

Contact Information

Formerly Known As
eXegenics, Cytoclonal Pharmaceutics, Cytoclonal Pharmaceutics Inc
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States
+1 (305)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States
+1 (305)

OPKO Health Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OPKO Health Stock Performance

As of 05-Feb-2025, OPKO Health’s stock price is $1.61. Its current market cap is $1.08B with 673M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.61 $1.56 $0.86 - $1.76 $1.08B 673M 4M -$0.19

OPKO Health Financials Summary

As of 30-Sep-2024, OPKO Health has a trailing 12-month revenue of $711M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,259,933 1,336,516 1,077,248 3,372,950
Revenue 711,408 863,495 1,004,196 1,774,718
EBITDA 13,919 (69,499) (272,791) 83,543
Net Income (133,734) (188,863) (328,405) (30,143)
Total Assets 2,256,103 2,011,698 2,167,259 2,399,715
Total Debt 512,316 326,564 305,548 254,755
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OPKO Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OPKO Health‘s full profile, request access.

Request a free trial

OPKO Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs.
Drug Discovery
Miami, FL
3,930 As of 2023

Basel, Switzerland
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OPKO Health Competitors (52)

One of OPKO Health’s 52 competitors is Novartis, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland
EMD Serono Corporation Boston, MA
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Roche Corporation Basel, Switzerland
GSK Corporation Middlesex, United Kingdom
You’re viewing 5 of 52 competitors. Get the full list »

OPKO Health Patents

OPKO Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2991898-A1 Heteroaryl carbonitriles for the treatment of disease Inactive 15-Jul-2015
US-20180153872-A1 Heteroaryl carbonitriles for the treatment of disease Inactive 15-Jul-2015
EP-3322422-A1 Heteroaryl carbonitriles for the treatment of disease Inactive 15-Jul-2015
US-20240148694-A1 Treatment of androgen deprivation therapy associated symptoms Pending 11-Sep-2014
CA-2814951-A1 Hypersulfated disaccharides to treat elastase related disorders Inactive 29-Oct-2010 A61K31/7016
To view OPKO Health’s complete patent history, request access »

OPKO Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OPKO Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OPKO Health‘s full profile, request access.

Request a free trial

OPKO Health Investments & Acquisitions (44)

OPKO Health’s most recent deal was a Merger/Acquisition with ModeX Therapeutics for . The deal was made on 09-May-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ModeX Therapeutics 09-May-2022 Merger/Acquisition Biotechnology
HealthSnap 01-Nov-2021 Later Stage VC Outcome Management (Healthcare)
Joint Venutre (LeaderMed Health Group / OPKO Health) 14-Sep-2021 Joint Venture Drug Discovery
Eloxx Pharmaceuticals 02-Aug-2017 Later Stage VC Biotechnology
VBI Vaccines 06-Dec-2016 PIPE Drug Discovery
You’re viewing 5 of 44 investments and acquisitions. Get the full list »

OPKO Health ESG

Risk Overview

Risk Rating

Updated July, 13, 2024

32.4 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Pharmaceuticals

Industry

of 853

Rank

Percentile

Biotechnology

Subindustry

of 368

Rank

Percentile

To view OPKO Health’s complete esg history, request access »

OPKO Health Exits (12)

OPKO Health’s most recent exit was on 02-Aug-2017 from Eloxx Pharmaceuticals. The exit was categorized as with 12 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Eloxx Pharmaceuticals 02-Aug-2017 Completed
  • 12 buyers
VBI Vaccines 06-Dec-2016 Completed
  • 4 buyers
Arno Therapeutics 16-Aug-2016 Completed
  • 6 buyers
VBI Vaccines 21-Jun-2016 Completed
  • 3 buyers
Sevion Therapeutics 01-Aug-2015 PIPE Completed
  • 2 buyers
You’re viewing 5 of 12 exits. Get the full list »

Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
EirGen Pharma Waterford, Ireland 2006
OPKO Biologics Kiryat Gat, Israel 2001
BioReference Health Elmwood Park, NJ 1981

OPKO Health FAQs

  • When was OPKO Health founded?

    OPKO Health was founded in 1991.

  • Where is OPKO Health headquartered?

    OPKO Health is headquartered in Miami, FL.

  • What is the size of OPKO Health?

    OPKO Health has 3,930 total employees.

  • What industry is OPKO Health in?

    OPKO Health’s primary industry is Drug Discovery.

  • Is OPKO Health a private or public company?

    OPKO Health is a Public company.

  • What is OPKO Health’s stock symbol?

    The ticker symbol for OPKO Health is OPK.

  • What is the current stock price of OPKO Health?

    As of 05-Feb-2025 the stock price of OPKO Health is $1.61.

  • What is the current market cap of OPKO Health?

    The current market capitalization of OPKO Health is $1.08B.

  • What is OPKO Health’s current revenue?

    The trailing twelve month revenue for OPKO Health is $711M.

  • Who are OPKO Health’s competitors?

    Novartis, EMD Serono, Intas Pharmaceuticals, Roche, and GSK are some of the 52 competitors of OPKO Health.

  • What is OPKO Health’s annual earnings per share (EPS)?

    OPKO Health’s EPS for 12 months was -$0.19.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »